The Cross-Border Biotech Blog

Biotechnology, Health and Business in Canada, the United States and Worldwide

Tag Archives: British Columbia

Human Swine Influenza: Understaffed

The volume of Human Swine flu info has exceeded my ability to keep up.  I will try to post sporadically on interesting scientific, political or business implications.

In the meantime, I have added two widgets on the right side of this page:

  • Google news RSS for “swine”
  • Twitter RSS for #swineflu

That should help visitors keep up with the news and help me get back to my day/night job.

Also keep in mind:

  1. The CDC Swine Flu Page
  2. The WHO Swine Flu Page
  3. You can not catch swine flu by eating pork

Bookmark and Share

Human Swine Influenza Update: Canadian Cases Confirmed, Public Health Emergency Declared in U.S.

CDC transcript from today’s briefing.

White House Press Briefing transcript.

New York Times story:

  • Mexico data: 1,300 infected, 80 dead.
  • U.S. data: 20 infected, one temporarily hospitalized now recovered.
  • Canada data: 6 infected, all linked to travel to Mexico. 2 in BC, 4 in Nova Scotia.
  • No WHO decision on pandemic alert level until Tuesday.

Bookmark and Share

Wednesday Brain Dump: February 25, 2009

The question this week: a shot in the arm or a kick in the teeth?

A shot in the arm for:

  • Fewer shots in the arm! (har) 
    • British Columbia is the first jurisdiction in North America to offer a children’s vaccine called Infanrix-hexa™, which contains six immunizations in one, resulting in three fewer needles in the overall B.C. infant vaccine schedule, and
    • With the discovery of a constant region of flu virus protein hemagglutinin, a universal flu vaccine may be possible (no more yearly shots);
  • The Naval Surface Warfare Center in White Oak, a suburb of Washington, where the FDA is spending $1.15 billion to consolidate its offices and labs and to anchor a new biotech hub;
  • Pine Island, near Rochester, Minnesota, which could soon be the home to a new biotech research, development and manufacturing park with the help of up to $900 million in funding reportedly pledged by Steve Burrill.  Funding announcements also from Maryland and Pittsburgh;
  • Sustainable agriculture, when the White House announced its nominee for second-in-command at USDA: Kathleen Merrigan of Tufts University, who had been a top choice of the Cornucopia Institute to run USDA’s National Organic Program;
  • The National Science Foundation, from the stimulus (a $3 billion boost) and the budget (a 6.7% increase, to $6.49 billion);
  • Multiple Sclerosis, with Merck, Novartis, Teva, Biogen Idec and Sanofi Aventis all planning to release new oral therapeutics between now and 2012;
  • Conflict of interest disclosure, with a new editorial in PLoS Medicine;
  • Deterrence, with the arrest of four animal-rights extremists;
  • Organ failure biomarkers,
    • with the discovery of liver toxicity-associated MicroRNAs, and
    • with the injection by Pfizer Canada of $1 million to the PROOF Centre to fund research into vital organ failure biomarkers; and
  • Aliens.

A kick in the teeth for:

Bookmark and Share

Follow

Get every new post delivered to your Inbox.

Join 129 other followers